SCHEMBL24023165

SCHEMBL24023165

CNC(=O)c1ccc(-c2ccc(C(C)C)cc2)c(C(C)C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 10/20 0.46
▸ HDAC2 Q92769 7/20 0.43
▸ HDAC3 O15379 6/20 0.43
▸ HDAC1 Q13547 6/20 0.43
▸ HDAC8 Q9BY41 6/20 0.43
▸ TLR9 Q9NR96 1/20 0.40
▸ TLR8 Q9NR97 1/20 0.40
▸ TLR7 Q9NYK1 1/20 0.40
▸ ROCK2 O75116 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24023157 0.88 GAA (0.47) HDAC6HDAC2HDAC1HDAC8TLR9
SCHEMBL24023216 0.83 PLK1 (0.44) HDAC6HDAC2HDAC3HDAC1HDAC8
SCHEMBL19391346 0.81 HDAC2 (0.53) HDAC6HDAC2HDAC8CYP2C9MEN1
SCHEMBL105171 0.79 HDAC6 (0.59) HDAC6HDAC2HDAC1HDAC8CYP2C9
SCHEMBL24252035 0.76 HPGD (0.47) HDAC6HDAC2HDAC8MEN1KMT2A
SCHEMBL19369014 0.76 CRBN (0.54) HDAC6HDAC8ROCK2CYP1A2CYP2C9
SCHEMBL8676137 0.75 LMNA (0.48) HDAC6MEN1KMT2ANPC1RAB9A
SCHEMBL19346306 0.74 HTT (0.48) HDAC6HDAC2HDAC1HDAC8TLR8
SCHEMBL24807366 0.74 KIF11 (0.45) HDAC6HDAC2HDAC3HDAC1HDAC8
SCHEMBL3110462 0.73 CHEK2 (0.41) HDAC6HDAC2HDAC8SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11174281-B1 Modified nucleotides and uses thereof Singular Genomics Systems, Inc. (US) 2021-11-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174281-B1 Modified nucleotides and uses thereof NUDT1, RNMT, ADAR HDAC6 2599/4885HDAC2 4317/4885HDAC3 3420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback